Cargando…
Escherichia Coli: an Important Pathogen in Patients with Hematologic Malignancies
BACKGROUND: Escherichia coli (E. coli) is a pathogen of great concern in immunosuppressed patients. While antimicrobial prophylactic therapy has become the standard, the emergence of resistant pathogens has some questioning its use. This study describes our experience with E.coli as a pathogen in ne...
Autores principales: | Olson, Daniel, Yacoub, Abraham T., Gjini, Anita D., Domingo, Gelenis, Greene, John N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235435/ https://www.ncbi.nlm.nih.gov/pubmed/25408854 http://dx.doi.org/10.4084/MJHID.2014.068 |
Ejemplares similares
-
478. Outcomes of Extended-Spectrum β-Lactamase-Producing Escherichia coli Bloodstream Infection in Neutropenic Patients with Hematological Malignancies
por: Aslam, Sadaf, et al.
Publicado: (2019) -
1466 Primary Cutaneous Mold Infections in Hematologic Malignancy with a Review of the Literature
por: Mai, Jane, et al.
Publicado: (2014) -
Targeting nuclear import and export in hematological malignancies
por: Nachmias, Boaz, et al.
Publicado: (2020) -
FNR Regulates the Expression of Important Virulence Factors Contributing to the Pathogenicity of Avian Pathogenic Escherichia coli
por: Barbieri, Nicolle L., et al.
Publicado: (2017) -
Are non-lactose-fermenting Escherichia coli important diarrhoeal pathogens in children and adults?
por: Sharma, Bhawna, et al.
Publicado: (2023)